Acrivon Therapeutics Inc (ACRV) PT Lowered to $27 at BMO Capital Nov 14, 2024 07:53AM
BMO Capital Reiterates Outperform Rating on Acrivon Therapeutics Inc (ACRV) Aug 14, 2024 10:04AM
BMO Capital Reiterates Outperform Rating on Acrivon Therapeutics Inc (ACRV) May 14, 2024 09:24AM
Acrivon Therapeutics Inc (ACRV) PT Raised to $25 at BMO Capital Apr 26, 2024 08:27AM